About This Research Study
Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. It affects the nose, throat, and sometimes the lungs, and can range in severity from mild to severe. Tekton Research is now enrolling participants in a clinical trial evaluating two flu vaccines that are already approved and commonly used in adults 65 and older. Qualified participants may be compensated up to $325 for time and travel.
Eligible participants…
- Must be 65 years or older
- Must not have received any influenza vaccine within the past 6 months
- May receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.